UA81608C2 - A synergistic pharmaceutical combination for the prevention or treatment of diabetes - Google Patents
A synergistic pharmaceutical combination for the prevention or treatment of diabetesInfo
- Publication number
- UA81608C2 UA81608C2 UA2004021166A UA2004021166A UA81608C2 UA 81608 C2 UA81608 C2 UA 81608C2 UA 2004021166 A UA2004021166 A UA 2004021166A UA 2004021166 A UA2004021166 A UA 2004021166A UA 81608 C2 UA81608 C2 UA 81608C2
- Authority
- UA
- Ukraine
- Prior art keywords
- prevention
- diabetes
- treatment
- pharmaceutical composition
- pharmaceutical combination
- Prior art date
Links
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title abstract 2
- 230000002195 synergetic effect Effects 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 abstract 4
- 239000012050 conventional carrier Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 230000003178 anti-diabetic effect Effects 0.000 abstract 1
- 230000001315 anti-hyperlipaemic effect Effects 0.000 abstract 1
- 239000003472 antidiabetic agent Substances 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention refers to a synergistic pharmaceutical composition which comprises (a) a first pharmaceutical composition containing аn antidiabetic or anti-hyperlipidemic active agent and one or more conventional carrier(s), and (b) a second pharmaceutical composition containing a hydroximic acid derivarive of the formula I and one or more conventional carrier(s). The pharmaceutical composition is suitable for the prevention or theatment of, among others, diabetes mellitus.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU0202204A HU226244B1 (en) | 2002-07-05 | 2002-07-05 | Pharmaceutical combination for the prophylaxis or treatment of diabetes |
| PCT/HU2002/000067 WO2003007951A1 (en) | 2001-07-17 | 2002-07-10 | A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA81608C2 true UA81608C2 (en) | 2008-01-25 |
Family
ID=89980598
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UA2004021166A UA81608C2 (en) | 2002-07-05 | 2002-07-10 | A synergistic pharmaceutical combination for the prevention or treatment of diabetes |
Country Status (2)
| Country | Link |
|---|---|
| HU (1) | HU226244B1 (en) |
| UA (1) | UA81608C2 (en) |
-
2002
- 2002-07-05 HU HU0202204A patent/HU226244B1/en not_active IP Right Cessation
- 2002-07-10 UA UA2004021166A patent/UA81608C2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HU0202204D0 (en) | 2002-09-28 |
| HU226244B1 (en) | 2008-07-28 |
| HUP0202204A2 (en) | 2003-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2407100A1 (en) | 1-aroyl-piperidinyl benzamidines | |
| IL159412A0 (en) | A synergistic pharmaceutical combination for the prevention or treatment of diabetes | |
| MXPA04004842A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| MXPA04004779A (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1. | |
| MY141661A (en) | 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases | |
| WO2004037181A3 (en) | Glycinenitrile-based inhibitors of dipeptidyl peptidase iv and methods | |
| WO1999063826A3 (en) | Agents for combating plant pests | |
| DZ3312A1 (en) | Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof | |
| MXPA04006553A (en) | 4-oxoquinoline compound and its use as hiv integrase inhibitor. | |
| WO2004018478A3 (en) | Synthesis of epothilones, intermediates thereto, analogues and uses thereof | |
| MY141243A (en) | Pharmaceutical compositions comprising metformine and glibenclamide for the treatment of type-ii diabetes mellitus | |
| WO2003024391A3 (en) | Treatment and prevention of mucositis in cancer patients | |
| WO1992019617A3 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
| MXPA05006889A (en) | Aromatic compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents. | |
| WO2002062322A3 (en) | Glycine betaine and its use as anti-hemorrhagic agent | |
| WO2004087880A8 (en) | Compounds and their use to treat diabetes and related disorders | |
| AU2001246999A1 (en) | New neurokinin antagonists for use as medicaments | |
| AU2001256727A1 (en) | Preventive or therapeutic drugs for cancers containing cyanidin compounds as theactive ingredient | |
| UA81608C2 (en) | A synergistic pharmaceutical combination for the prevention or treatment of diabetes | |
| IL159841A0 (en) | Pharmaceutical composition for the treatment of the decline and/or damage of cognitive functions | |
| PL314794A1 (en) | Crystalline polymorphous form of (s,s,s)-n-(1-[2-carbocy-3-(n2-mezilolysilamino)propyl]-1-cyclopentylocabonyl)thyrosine | |
| TW200640464A (en) | Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient | |
| WO2003095453A1 (en) | Compounds against helicobacter activity | |
| GEP20084343B (en) | Use of indole derivatives for the treatment of neuropathic pain | |
| EP1541553A4 (en) | Novel indoline compound and medicinal use thereof |